Skip to main content
Log in

Pathogenesis of Type 2 Diabetes

Implications for Metformin

  • Short Communication
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1998; 37: 667–87

    Google Scholar 

  2. DeFronzo RA. Pathogenesis of type 2 diabetes: metabolic andmolecular implications for identifying diabetes genes. Diabetes Rev 1997; 5: 177–269

    Google Scholar 

  3. Gulli G, Ferrannini E, Stern M, at al. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 1992; 41: 1575–86

    Article  PubMed  CAS  Google Scholar 

  4. DeFronzo RA, Ferrannini E, Simonson DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 1989; 38: 387–95

    Article  PubMed  CAS  Google Scholar 

  5. Consoli A, Nurjhan N, Capani F, et al. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 1989; 38: 550–7

    Article  PubMed  CAS  Google Scholar 

  6. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992; 15: 318–68

    Article  PubMed  CAS  Google Scholar 

  7. DeFronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 1995; 333: 541–9

    Article  PubMed  CAS  Google Scholar 

  8. Garber AJ, Duncan TG, Goodman AM, et al. Efficacy of metformin in type 2 diabetes: results of a double-blind, placebo-controlled, dose response trial. Am J Med 1997; 103(6): 491–7

    Article  PubMed  CAS  Google Scholar 

  9. Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 4059–67

    Article  PubMed  CAS  Google Scholar 

  10. Stumvoll M, Nurjhan N, Perriello G, et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 550–4

    Article  PubMed  CAS  Google Scholar 

  11. Rosetti L, DeFronzo RA, Gherzi R, et al. Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations. Metabolism 1990; 39: 425–35

    Article  Google Scholar 

  12. Klip A, Leiter LA. Cellular mechanism of action of metformin. Diabetes Care 1990; 13: 696–704

    Article  PubMed  CAS  Google Scholar 

  13. Inzucchi SE, Maggs DG, Spollett GR, et al. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 1998; 338: 867–72

    Article  PubMed  CAS  Google Scholar 

  14. Giugliano D, Quatrano A, Consoli G, et al. Metformin for obese, insulin resistant diabetic patients: improvement in glycemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol 1993; 44: 107–12

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

DeFronzo, R.A. Pathogenesis of Type 2 Diabetes. Drugs 58 (Suppl 1), 29–30 (1999). https://doi.org/10.2165/00003495-199958001-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199958001-00008

Keywords

Navigation